Form 4: West Pharmaceutical Services Director Thomas Hofmann Reports Sale of Common Stock

Director Thomas Hofmann reported the sale of 617 shares of West Pharmaceutical Services Inc. common stock at a price of $365.92 per share on May 10, 2024.

Summary

• On May 10, 2024, Thomas Hofmann, a director of West Pharmaceutical Services Inc., sold 617 shares of common stock.
• The sale price was $365.92 per share.
• Following the transaction, Hofmann directly owns 43,564.68 shares of West Pharmaceutical Services Inc.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing reporting a stock sale by a company director, which doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard disclosures required by the SEC for insiders (officers, directors, and large shareholders) to report transactions in their company's stock, providing transparency to the market.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies and their insiders, ensuring compliance with SEC regulations.
• Similar filings are made by insiders at comparable pharmaceutical and healthcare companies like Johnson & Johnson, Pfizer, and Abbott Laboratories, providing insights into their trading activities.

Stakeholder Impact

• The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and reasons for the sale.
• However, single transactions are unlikely to have a significant impact.

Key Dates